Avidity Biosciences Inc
Avidity Biosciences Inc (RNAM) Stock Overview
Explore Avidity Biosciences Inc’s financial performance, market position, analyst ratings, and future outlook.
Key Financials
Key Financials
Market Cap
10.6B
P/E Ratio
-15.89
EPS (TTM)
N/A
ROE
-0.45%
RNAM Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Avidity Biosciences Inc (RNAM) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of C+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
Our forecasting models predict significant price movements, with a 12-month target of N/A.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -15.89 and a market capitalization of 10.6B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.